NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.
Don't have an account? Subscribe
The 2022 Irish Society of Medical Oncology (ISMO) Bursary Awards took place on Friday, 28 January. Once again, the meeting was held virtually as a result of the Covid-19 pandemic and was streamed live from the Fintan Gunne Theatre, Catherine McCauley Centre, the Mater Misericordiae University Hospital (MMUH), Dublin.
The use of a novel agent, sacituzumab govitecan, an antibody-drug conjugate, resulted...
Ibrutinib combined with bendamustine-rituximab improved PFS by 50 per cent for older patients with newly-diagnosed mantle...
The use of panitumumab plus mFOLFOX6 significantly improved OS in patients with RAS wild-type...
The use of autologous stem cell transplant (ASCT) early in the course of treatment showed a...
The addition of nimotuzumab to gemcitabine increases OS in patients with KRAS wild-type advanced...
New research has provided important insight into what drives metastases in prostate cancer...
The National Cancer Control Programme (NCCP) has launched a framework for the care and support of...
In the last three years, there has been a rapid shift in the treatment landscape for...
n Ireland, the incidence of melanoma has increased in both sexes since 1994, with melanoma accounting...
More than half of patients diagnosed with advanced non-small cell lung cancer (NSCLC)...
While still generally incurable, there are a range of treatment approaches for chronic lymphocytic...
The 2022 Irish Society of Medical Oncology (ISMO) Bursary Awards took place on Friday...